News

Cravath Welcomes National Security Heavyweight Michael Daly

Cravath Welcomes National Security Heavyweight Michael Daly

Daly's Tactical Move to Cravath

Some days, the headlines read like chess moves in the world of corporate lawyering. June 1, 2026, is one of those days, with Michael Patrick Daly, a name known in National Security Division circles, sidling up to Cravath, Swaine & Moore LLP as a partner. Over in Washington, D.C., they're surely set for a power talk over coffee—this isn't just a plop into a chair kind of gig.

Adding Muscle to Their Regulatory Arsenal

Daly’s no rookie to the labyrinth of CFIUS regulations, and entering Cravath’s Corporate Department, he’s expected to turn his ten-plus years at the DOJ into gold—or at least some smooth sailing through the tricky waters of cross-border investments. With global clients stepping on eggshells over regulatory hurdles, his know-how can’t come cheap. Faiza J. Saeed, Cravath's Presiding Partner, can barely contain her excitement as she waxes lyrical about Daly’s chops in national security and foreign investments.

Who’s Who at Cravath’s D.C. Office

It’s not a one-man show over at their D.C. office, though. The lineup looks like a gathering of legal Avengers. From Jennifer S. Leete to Jeffrey T. Dinwoodie, each plays a distinct role in regulatory or enforcement spheres. They've all dipped their toes in federal stirrups before. Consolidating former heavyweights like Noah Joshua Phillips from the FTC adds layers of compliance expertise. It’s like Cravath’s building an all-star legal team, each member armed with the experience to fend off compliance headaches.

Daly's Decorated DOJ Tenure

“Cravath is widely known for its depth of expertise across the most complex transactional and regulatory matters,” exclaims Daly. Three Assistant Attorney General Awards in his back pocket ain’t shabby, validating his critical eye on national security.

Daly's resume isn’t just a paperweight. Those 2019 to 2024 years at the NSD weren’t just clocking hours. Heck, handling delicate counterintelligence operations isn't for the faint of heart.

Implications for Cross-Border Business

Folks eyeing the U.S. for investment best watch this space closely. Daly’s gravitational pull in understanding how CFIUS zeros in on security risks isn’t just a boon for Cravath — it’s an edge for global clientele.* The intersection of technology, investment, and national security issues is a legal minefield. A firm like Cravath having a guy who knows those maps might be the safe path many companies seek.*

A Boost for Cravath's Prestige

Cravath, a name embroidered into the fabric of law pretty much since forever, stands to gain more than just a flashy new partner. With offices in the triad of power: New York, London, and Washington, D.C., this isn’t just adding a piece to the board—it’s upgrading to a heavier piece, one that maneuver through obstacles smoothly, with a force that's hard to reckon with.

Final Thoughts

Adding Michael Daly to Cravath's mix isn’t just tweaking playbooks. It's a step up, broadening their package of solutions to investment woes tied to national security claws. For those entrenched in high-stakes cross-border transactions, the signal’s clear — navigating through regulatory mazes is Cravath’s game, and they just bolstered their team with a virtuoso. Now let's see how he plays it in this new sandbox.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lauletta Birnbaum Earns Distinction in 2026 Chambers Guide

Updated Category News Views 209

Lauletta Birnbaum Recognized in the 2026 Chambers Spotlight Guide Lauletta Birnbaum has received prestigious recognition in the 2026 Chambers Spotlight Guide in the category of Corporate/Commercial Law. This honor highlights the firm's commitment to providing exceptional legal services to its clients. The Importance of Legal Recognition Chambers and Partners is recognized...

Continue Reading
Medicenna Therapeutics Showcases Advances in Cancer Treatment

Updated Category News Views 127

Medicenna Therapeutics Showcases Advances in Cancer Treatment Medicenna Therapeutics Corp. is making notable strides in the field of cancer immunotherapy. With a focus on developing innovative therapies, the company is gaining attention for its promising Superkines targeting a range of conditions, including cancer. One of their leading programs, MDNA11, has showcased...

Continue Reading
DÉKUPLE Reports Strong Growth in First-Half Earnings 2024

Updated Category News Views 258

DÉKUPLE reported its first-half earnings for 2024, showcasing an 8.8% rise in net sales, totaling €104.6 million. The figures signal a resilient company navigating a turbulent economic backdrop, but traders are already weighing the potential fallout. Key Financial Metrics: Profitability vs. Economic Headwinds The group's gross margin jumped 5.8%, hitting €83.5...

Continue Reading
Main Street Capital Corporation Declares 2025 Dividend Increases

Updated Category News Views 220

Regular Monthly Dividends Announced by Main Street Capital Main Street Capital Corporation (NYSE: MAIN) has taken a significant step forward in announcing its regular monthly dividends for the early part of 2025. The Board of Directors has declared a monthly dividend of $0.25 per share for January, February, and March of that year. This move showcases the company's...

Continue Reading
Exciting New Travel Offers Just for Travelzoo Club Members

Updated Category News Views 306

Exclusive Travel Offers for Club Members Travelzoo® (NASDAQ: TZOO), a leading platform for travel enthusiasts, has rolled out an enticing set of offers tailored specifically for its Club Members. These deals are meticulously negotiated to provide the best experiences at the most competitive prices. Whether you're looking for adventure or relaxation, there's something for...

Continue Reading